Skip to content
HeyJared

Mendelspod

The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.

Newsletter · By Theral Timpson · English · Paid tier available · Official site

Part of Mendelspod Podcast. Follow the publication for all its platforms.

Indexed issues, last 90 days
14
Latest publication
Sep 29, 2026
Audience
Checking…
Earliest in this view
Jul 30, 2026

Latest issues

  1. Issue · Sep 29, 2026

    Deeper into Genomics: Google DeepMind’s Ziga Avsec on the New AlphaGenome Atlas (opens the original)

    Excerpt · Neutral tone

    Read excerpt

    Is biology headed back into the genome?While much of biology has been expanding outward into single cells, spatial biology and ever more biological context, Žiga Avsec and his team at Google DeepMind are making the case that there is still an enormous amount to learn by going deeper into DNA itself.Their new AlphaGenome Atlas uses AlphaGenome to predict the molecular effects of every possible single letter change in the human genome. That’s some nine billion variants. Now researchers can easily

  2. Issue · Sep 22, 2026

    Mass Spec Comes to the Routine Core Lab: Don Mason of Roche on a New Era in Clinical Testing (opens the original)

    Excerpt

    Read excerpt

    Mass spectrometry has been one of the most powerful technologies in clinical testing for decades. So why is it still largely confined to specialty labs?Don Mason has spent more than 25 years in clinical mass spectrometry. Now Senior Marketing Manager for Mass Spectrometry at Roche Diagnostics, he says the technology’s strength has also been its weakness: “Part of its power and part of its challenges are linked.” Mass spec is extraordinarily sensitive, selective and flexible, but traditionally re

  3. Issue · Sep 11, 2026

    It’s One of the Greatest Success Stories of Molecular Medicine. Genomics Historian Kevin Davies on His Latest Book about Casgevy and Sickle Cell Disease (opens the original)

    Episode notes · Positive tone

    Read excerpt

    This is a free preview of a paid episode. To hear more, visit www.mendelspod.com It was the heady days of the CRISPR revolution and of the gene therapy Casgevy. And when longtime genomics editor and author Kevin Davies went looking for a book that told the story of sickle cell disease and could not find one, he was perplexed and then inspired. A few years later, the result is Curved Air , a biography of sickle cell anemia that traces one of the most remarkable arcs in modern biology. Davies begi

  4. Issue · Sep 10, 2026

    Elias Sayour on the Cancer Vaccine Breakthrough (opens the original)

    Episode notes · Neutral tone

    Read excerpt

    This is a free preview of a paid episode. To hear more, visit www.mendelspod.com After being pursued for more than 150 years, cancer vaccines may finally be having their moment. The recent positive Phase III results from Moderna and Merck offer what today’s guest Dr. Elias Sayour calls the first “bona fide evidence” that a therapeutic personalized cancer vaccine can work. For Sayour, a pediatric oncologist and cancer researcher at the University of Florida, the result is not the culmination of t

  5. Issue · Sep 8, 2026

    What Single Cell Sequencing Revealed About Pulmonary Fibrosis with Nick Banovich, TGen (opens the original)

    Episode notes

    Read excerpt

    Single cell sequencing has given researchers extraordinary new maps of human biology. For Nick Banovich of TGen, the burning question is how to turn those maps into something that matters for patients. Banovich has spent much of his career studying pulmonary fibrosis, and single cell sequencing has changed the field’s understanding of the disease. Instead of looking at an average signal from diseased lung tissue, researchers can now separate molecular changes from changes in the populations of c

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Mendelspod